» Articles » PMID: 30352600

The Role of Integration and Clonal Expansion in HIV Infection: Live Long and Prosper

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2018 Oct 25
PMID 30352600
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Integration of viral DNA into the host genome is a central event in the replication cycle and the pathogenesis of retroviruses, including HIV. Although most cells infected with HIV are rapidly eliminated in vivo, HIV also infects long-lived cells that persist during combination antiretroviral therapy (cART). Cells with replication competent HIV proviruses form a reservoir that persists despite cART and such reservoirs are at the center of efforts to eradicate or control infection without cART. The mechanisms of persistence of these chronically infected long-lived cells is uncertain, but recent research has demonstrated that the presence of the HIV provirus has enduring effects on infected cells. Cells with integrated proviruses may persist for many years, undergo clonal expansion, and produce replication competent HIV. Even proviruses with defective genomes can produce HIV RNA and may contribute to ongoing HIV pathogenesis. New analyses of HIV infected cells suggest that over time on cART, there is a shift in the composition of the population of HIV infected cells, with the infected cells that persist over prolonged periods having proviruses integrated in genes associated with regulation of cell growth. In several cases, strong evidence indicates the presence of the provirus in specific genes may determine persistence, proliferation, or both. These data have raised the intriguing possibility that after cART is introduced, a selection process enriches for cells with proviruses integrated in genes associated with cell growth regulation. The dynamic nature of populations of cells infected with HIV during cART is not well understood, but is likely to have a profound influence on the composition of the HIV reservoir with critical consequences for HIV eradication and control strategies. As such, integration studies will shed light on understanding viral persistence and inform eradication and control strategies. Here we review the process of HIV integration, the role that integration plays in persistence, clonal expansion of the HIV reservoir, and highlight current challenges and outstanding questions for future research.

Citing Articles

Aberrant DNA methylation of genes regulating CD4+ T cell HIV-1 reservoir in women with HIV.

Xu K, Zhang X, Asam K, Quach B, Page G, Konkle-Parker D Clin Transl Med. 2025; 15(3):e70267.

PMID: 40070009 PMC: 11896887. DOI: 10.1002/ctm2.70267.


HIV-1 gp120 Interactions with Nicotine Modulate Mitochondrial Network Properties and Amyloid Release in Microglia.

Graur A, Erickson N, Sinclair P, Nusir A, Kabbani N Neurochem Res. 2025; 50(2):103.

PMID: 39992414 PMC: 11850467. DOI: 10.1007/s11064-025-04357-3.


Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV.

Campagna R, Nonne C, Antonelli G, Turriziani O Viruses. 2024; 16(11).

PMID: 39599811 PMC: 11599110. DOI: 10.3390/v16111697.


Help or Hinder: Protein Host Factors That Impact HIV-1 Replication.

Moezpoor M, Stevenson M Viruses. 2024; 16(8).

PMID: 39205255 PMC: 11360189. DOI: 10.3390/v16081281.


Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview.

Henriquez R, Munoz-Barroso I Heliyon. 2024; 10(15):e34927.

PMID: 39144987 PMC: 11320483. DOI: 10.1016/j.heliyon.2024.e34927.


References
1.
Bangham C . Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis. Annu Rev Immunol. 2017; 36:43-71. DOI: 10.1146/annurev-immunol-042617-053222. View

2.
Cesana D, Santoni de Sio F, Rudilosso L, Gallina P, Calabria A, Beretta S . HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells. Nat Commun. 2017; 8(1):498. PMC: 5591266. DOI: 10.1038/s41467-017-00609-1. View

3.
von Wyl V, Gianella S, Fischer M, Niederoest B, Kuster H, Battegay M . Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS One. 2011; 6(11):e27463. PMC: 3216952. DOI: 10.1371/journal.pone.0027463. View

4.
Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

5.
Mocroft A, Vella S, Benfield T, Chiesi A, Miller V, Gargalianos P . Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998; 352(9142):1725-30. DOI: 10.1016/s0140-6736(98)03201-2. View